Cabozantinib has a similar target as votrient plus an additional target, which may be relevant to synovial sarcoma. It's a NIH trial, in Bestheda, Maryland:
http://clinicaltrials.gov/ct2/show/NCT01755195?term=Cabozantinib&rank=19
Thanks Elodie. Happy Holidays!
Happy Holidays to you too Scott!
Hi Elodie - My husband is currently in this trial and has shown a decrease in his tumor (located in the lining of his lung) after a few cycles. I am glad that you are sharing this as it may help others. My husband did the AIM chemo without any success and we tried to find an immunotherapy trial at first where he did not qualify and then found this one for Cabozantinib.
Thanks Cathy for sharing :-)